
Industry Trends
Latest News
Latest Videos

More News

President mentions some health care issues in address to Congress.

The transaction positions Wellvana as a leading value-based care enabler, extending services to approximately one million Medicare patients across 40 states.

Trump tariffs on imports and effects on health care, explained
President Trump says it’s necessary to impose extra costs on goods from Canada, Mexico and China. What does that mean for the health care sector? Potentially, a lot.

Author discusses new study that breaks down health care spending and medical conditions over a decade, and what that could mean for the future.

Executive order says HHS will ‘rapidly enforce’ price disclosures by hospitals, health insurers.

Author describes origin of new study that breaks down health care spending and medical conditions over a decade.

U.S. general public overestimated primary care funding by 10 times.

Author describes origin of new cost breakdown on health care spending over a decade.

AdvaMed, Senate Democrats warn of regulatory slowdowns and public health threats following mass layoffs at the FDA.

Insurers promised change after Brian Thompson’s murder, but some seem more committed that others

New study outlines health care spending down to the county level.

New study outlines health care spending down to the county level.

Scorecard has bad marks for health care system that devotes rhetoric and attention — but not money — to primary care.

U.S. health care system gets failing grade for supporting primary care, say Milbank Memorial Fund and the Physicians Foundation.

Prevention beats treatment for everyone — patients, payers and investors.

Health care spending has wide variation, with Type 2 diabetes as top condition, according to major study
Research estimates health care spending by conditions, age, types of care, down to county level.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Yale researchers revealed $2.6 trillion in payouts over two decades, raising concerns about affordability and reinvestment.

Other clinicians and patients all have a place in slowing the spread of antimicrobial resistance.

Screenings are also crucial, but prior authorization requirements create a barrier to care.

A recent Dartmouth study finds primary care practices struggling with accessibility despite advances in practice capabilities since 2017-2018.

Expenses continued to rise throughout the year, but they did not outpace inflation

A family medicine specialist who works with cancer survivorship explains a study that shows how vital screenings are for patients.

An expert on antimicrobial resistance discusses how it involves patients in local doctors’ offices and around the world.

An analysis by Gibbins Advisors.











